Indian equity market saw a mixed bag of performances on Monday. Among the top performers, CreditAccess Grameen Limited and BSE Limited emerged as the notable gainers, while SJVN Limited and Jubilant Pharmova Limited were among the top losers.
Microfinance service provider CreditAccess Grameen witnessed an impressive gain of 8.45%, reaching ₹1507.40 from its last close at ₹1389.85. The company offers microcredit loans for income generation, home improvement, emergency, and family welfare, amongst others.
|Stock||Current Price (₹)||Last Close (₹)||% Change|
|CreditAccess Grameen Limited||₹1507.4||₹1389.85||8.46%|
|Ipca Laboratories Limited||₹998.8||₹935.9||6.72%|
|Rainbow Children’s Medicare Limited||₹1111.35||₹1076.55||3.23%|
|MedPlus Health Services Limited||₹801.25||₹784.9||2.08%|
|Stock||Current Price||Last Close||% Change|
|Jubilant Pharmova Limited||₹358.5||₹400.1||-10.4%|
|Rashtriya Chemicals and Fertilizers Limited||₹123.95||₹137.65||-9.95%|
|Finolex Industries Limited||₹202.65||₹224.85||-9.87%|
Following close on the heels was BSE Limited, which recorded a 7.51% surge, with its stocks trading at ₹1707.15, up from the previous close of ₹1587.80. The surge in the stock came as it made changes to its forcing structure.
On the flip side, SJVN Limited, involved in the generation and sale of electricity in India, Nepal, and Bhutan, dropped by a whopping 11.94%, with its current price at ₹66.35, down from ₹75.35.
Get all the latest Share Market trends and news to set you up for the week ahead.
Pharma major Jubilant Pharmova Limited also had a tough day at the market, with a decline of 10.39%, trading at ₹358.50, down from the last close of ₹400.10. The company operates as an integrated pharmaceutical and life sciences company in India and internationally.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.